Numerous women around the world suffer from breast cancer and others think of it as a death sentence for them.
It is estimated that there is one out of 8 women who will develop this kind of cancer at some point of their life, but these days, scientists that came from Amsterdam may actually provide hope in their discover and may save millions of lives of women.
Professor Nigel Bundred has presented the result and findings of a recent research that was conducted at the European Breast Cancer Conference in Amsterdam, which served to calculate the effects of several drugs such as Herceptin or also known as trastuzumab and Lapatinib.
These medicaments have been already used in handling cancer, but this was the very first time that they have used it together in combination, before any other conservative treatments, which includes surgery or chemo.
These scientists have found out that this combination can effectively destroy breast cancer in just 11 days!
The research has been founded by the Cancer Research UK, and the goal that they have was to use these two different drugs to battle against a protein that is called as HER2 or also known as Human Epidermal Growth Factor Receptor 2. It has the ability to influence the division, as well as the development of cancer cells, and there are more chances that it will return than other kinds of cancer.
The surprising and the best thing about this treatment is its ability to completely leave out chemo and surgery, as well as their temporary side effects, which includes:
- Hair loss
More and more people are becoming aware of the fact that chemotherapy is far from a beneficial treatment, so it is more than welcome to avoid this kind of treatment and to try some other effective alternatives.
Researchers have involved over 257 women in the study, which all are HER2 positive breast cancer. Half of these women were the control group that only received Herceptin, while the other half used the combination of these two drugs.
Here are the results of the research:
- There are 11% of those women who took the combination drug had seen no cancer cells remaining in just two weeks and about 17% of cases have bring forward intensely shrunken tumors.
- In order to compare to the control group, they had 0% with no trace of cancer cells and only 3% of them who have shown a drop in the size of the tumor.
- The combination of the drugs has extremely high beneficial effects in the case of treating breast cancer, as opposed to their results if it is used on their own. However, the issue that is coming out is that licensing only allows its use together with chemotherapy and not alone. Nevertheless, these findings may greatly contribute for a bigger change.
- This research is a great step forward in the battle against lethal diseases, but these findings need to be examined further on.
Nonetheless, this research have provided hope that scientists are working hard just to find a treatment, so people are enthusiastically waiting for new improvements on the field.
We hope that this brief and informative article have helped you, share this post so that you can inform others as well and this article might help them too.